179 related articles for article (PubMed ID: 33046409)
1. Electronic FRAIL score may predict treatment outcomes in older adults with myeloma.
Chan H; Chong YH; Seow MY; Li J; Garg P; Kelly M; Neylon A; McDiarmid B; Tan S; Jackson S
J Geriatr Oncol; 2021 May; 12(4):515-520. PubMed ID: 33046409
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.
Lee HS; Kim K; Lee JJ; Yoon SS; Bang SM; Kim JS; Eom HS; Yoon DH; Lee Y; Shin HJ; Park Y; Jo JC; Lee WS; Do YR; Mun YC; Lee MH; Kim HJ; Kim SH; Kim MK; Lim SN; Park SK; Yi JH; Lee JH; Min CK;
Int J Hematol; 2021 Jan; 113(1):81-91. PubMed ID: 32889695
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty.
Murugappan MN; King-Kallimanis BL; Bhatnagar V; Kanapuru B; Farley JF; Seifert RD; Stenehjem DD; Chen TY; Horodniceanu EG; Kluetz PG
J Geriatr Oncol; 2024 Mar; 15(2):101681. PubMed ID: 38104480
[TBL] [Abstract][Full Text] [Related]
5. Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population.
Lee HS; Lee J; Jo JC; Jung SH; Lee JJ; Kim D; Lee S; Song K
Sci Rep; 2021 Nov; 11(1):22907. PubMed ID: 34824362
[TBL] [Abstract][Full Text] [Related]
6. Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75 years.
Belotti A; Ribolla R; Cancelli V; Crippa C; Bianchetti N; Ferrari S; Bottelli C; Cattaneo C; Tucci A; De La Fuente Barrigon C; Rossi G
Am J Hematol; 2020 Jul; 95(7):759-765. PubMed ID: 32242970
[TBL] [Abstract][Full Text] [Related]
7. Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Auner HW; Gavriatopoulou M; Delimpasi S; Simonova M; Spicka I; Pour L; Dimopoulos MA; Kriachok I; Pylypenko H; Leleu X; Doronin V; Usenko G; Hajek R; Benjamin R; Dolai TK; Sinha DK; Venner CP; Garg M; Stevens DA; Quach H; Jagannath S; Moreau P; Levy M; Badros A; Anderson LD; Bahlis NJ; Facon T; Mateos MV; Cavo M; Chai Y; Arazy M; Shah J; Shacham S; Kauffman MG; Richardson PG; Grosicki S
Am J Hematol; 2021 Jun; 96(6):708-718. PubMed ID: 33755235
[TBL] [Abstract][Full Text] [Related]
8. More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected].
DuMontier C; La J; Bihn J; Corrigan J; Yildirim C; Dharne M; Hassan H; Yellapragada S; Abel GA; Gaziano JM; Do NV; Brophy M; Kim DH; Munshi NC; Fillmore NR; Driver JA
Blood Adv; 2023 Oct; 7(20):6275-6284. PubMed ID: 37582048
[TBL] [Abstract][Full Text] [Related]
9. Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older.
Murillo A; Cronin AM; Laubach JP; Hshieh TT; Tanasijevic AM; Richardson PG; Driver JA; Abel GA
J Geriatr Oncol; 2019 May; 10(3):486-489. PubMed ID: 30472368
[TBL] [Abstract][Full Text] [Related]
10. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.
Efficace F; Gaidano G; Petrucci MT; Niscola P; Cottone F; Codeluppi K; Antonioli E; Tafuri A; Larocca A; Potenza L; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Kyriakou C; Cascavilla N; Gozzetti A; Derudas D; Vignetti M; Cavo M
Lancet Healthy Longev; 2022 Sep; 3(9):e628-e635. PubMed ID: 36102777
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.
Yao Y; Sui WW; Liao AJ; Wang W; Chen LJ; Chu XX; Bao L; Cen XN; Fu R; Liu H; Sun CY; Jin FY; Yan H; Wang LQ; Yuan CL; Gao GX; Gao D; Zhang JQ; He JX; Hu JD; Ma LM; Zhang L; Zhou DB; Zou DH; Li J
Age Ageing; 2022 Jan; 51(1):. PubMed ID: 34673897
[TBL] [Abstract][Full Text] [Related]
12. Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).
Brioli A; Manz K; Pfirrmann M; Hänel M; Schwarzer AC; Prange-Krex G; Fabisch C; Knop S; Illmer T; Krammer-Steiner B; Hochhaus A; von Lilienfeld-Toal M; Mügge LO
J Cancer Res Clin Oncol; 2020 Mar; 146(3):749-759. PubMed ID: 31788741
[TBL] [Abstract][Full Text] [Related]
13. Association of frailty with chemotherapy toxicity in chemotherapy-naive older patients with cancer.
Akbıyık I; Yüce D; Kars A; Halil MG
Support Care Cancer; 2022 Dec; 30(12):9975-9981. PubMed ID: 36357794
[TBL] [Abstract][Full Text] [Related]
14. Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans.
Patel BG; Luo S; Wildes TM; Sanfilippo KM
JCO Clin Cancer Inform; 2020 Feb; 4():117-127. PubMed ID: 32083955
[TBL] [Abstract][Full Text] [Related]
15. FRAIL Questionnaire Screening Tool and Short-Term Outcomes in Geriatric Fracture Patients.
Gleason LJ; Benton EA; Alvarez-Nebreda ML; Weaver MJ; Harris MB; Javedan H
J Am Med Dir Assoc; 2017 Dec; 18(12):1082-1086. PubMed ID: 28866353
[TBL] [Abstract][Full Text] [Related]
16. Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma.
Mian HS; Wildes TM; Fiala MA
JCO Clin Cancer Inform; 2018; 2():. PubMed ID: 30547157
[TBL] [Abstract][Full Text] [Related]
17. Elderly patients with multiple myeloma: towards a frailty approach?
Zweegman S; Engelhardt M; Larocca A;
Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
[TBL] [Abstract][Full Text] [Related]
18. A comparison of three different approaches to defining frailty in older patients with multiple myeloma.
Isaacs A; Fiala M; Tuchman S; Wildes TM
J Geriatr Oncol; 2020 Mar; 11(2):311-315. PubMed ID: 31326393
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the Efficacy and Safety of Chemotherapy in Elderly Patients with Multiple Myeloma under Different Frailty Scores].
Xue R; Cheng L; Song LM; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):170-174. PubMed ID: 35123622
[TBL] [Abstract][Full Text] [Related]
20. Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
Salazar AS; Recinos LM; Mian HS; Stoll C; Simon LE; Sekhon S; Colditz GA; Wildes TM
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):488-496.e6. PubMed ID: 31133527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]